Which valuation approach is most appropriate for valuing a patent on a new pharmaceutical compound?
-
A
Cost approach using replacement cost new less depreciation
-
B
Market approach using comparable patent license transactions
-
C
Income approach using discounted expected future royalties or profits
-
D
Net asset value approach based on R&D expenditures